However, this mutation only accounts for a third of hyperhomocysteinemia cases, and the mutation itself is not associated with arterial thrombosis except in conjunction with hyperhomocysteinemia; therefore, the clinical use of MTHFR testing is less informative than plasma homocysteine measurement [22]. This evidence concerns the gene MTHFR and hyperhomocysteinemia.